DOI QR코드

DOI QR Code

Implantable cardioverter defibrillator therapy in pediatric and congenital heart disease patients: a single tertiary center experience in Korea

  • Jin, Bo Kyung (Department of Pediatrics, Seoul National University Children's Hospital) ;
  • Bang, Ji Seok (Department of Pediatrics, Seoul National University Children's Hospital) ;
  • Choi, Eun Young (Department of Pediatrics, Seoul National University Children's Hospital) ;
  • Kim, Gi Beom (Department of Pediatrics, Seoul National University Children's Hospital) ;
  • Kwon, Bo Sang (Department of Pediatrics, Seoul National University Children's Hospital) ;
  • Bae, Eun Jung (Department of Pediatrics, Seoul National University Children's Hospital) ;
  • Noh, Chung Il (Department of Pediatrics, Seoul National University Children's Hospital) ;
  • Choi, Jung Yun (Department of Pediatrics, Seoul National University Children's Hospital) ;
  • Kim, Woong Han (Department of Thoracic and Cardiovascular Surgery, Seoul National University Children's Hospital)
  • Received : 2012.09.11
  • Accepted : 2012.10.25
  • Published : 2013.03.15

Abstract

Purpose: The use of implantable cardioverter defibrillators (ICDs) to prevent sudden cardiac death is increasing in children and adolescents. This study investigated the use of ICDs in children with congenital heart disease. Methods: This retrospective study was conducted on the clinical characteristics and effectiveness of ICD implantation at the department of pediatrics of a single tertiary center between 2007 and 2011. Results: Fifteen patients underwent ICD implantation. Their mean age at the time of implantation was $14.5{\pm}5.4$ years (range, 2 to 22 years). The follow-up duration was $28.9{\pm}20.4$ months. The cause of ICD implantation was cardiac arrest in 7, sustained ventricular tachycardia in 6, and syncope in 2 patients. The underlying disorders were as follows: ionic channelopathy in 6 patients (long QT type 3 in 4, catecholaminergic polymorphic ventricular tachycardia [CPVT] in 1, and J wave syndrome in 1), cardiomyopathy in 5 patients, and postoperative congenital heart disease in 4 patients. ICD coils were implanted in the pericardial space in 2 children (ages 2 and 6 years). Five patients received appropriate ICD shock therapy, and 2 patients received inappropriate shocks due to supraventricular tachycardia. During follow-up, 2 patients required lead dysfunction-related revision. One patient with CPVT suffered from an ICD storm that was resolved using sympathetic denervation surgery. Conclusion: The overall ICD outcome was acceptable in most pediatric patients. Early diagnosis and timely ICD implantation are recommended for preventing sudden death in high-risk children and patients with congenital heart disease.

Keywords

References

  1. Cross BJ, Estes NA 3rd, Link MS. Sudden cardiac death in young athletes and nonathletes. Curr Opin Crit Care 2011;17:328-34. https://doi.org/10.1097/MCC.0b013e328348bf84
  2. Tester DJ, Ackerman MJ. Postmortem long QT syndrome genetic testing for sudden unexplained death in the young. J Am Coll Cardiol 2007;49:240-6. https://doi.org/10.1016/j.jacc.2006.10.010
  3. Wren C. Sudden death in children and adolescents. Heart 2002;88: 426-31. https://doi.org/10.1136/heart.88.4.426
  4. Kral MA, Spotnitz HM, Hordof A, Bigger JT Jr, Steinberg JS, Livelli FD Jr. Automatic implantable cardioverter defibrillator implantation for malignant ventricular arrhythmias associated with congenital heart disease. Am J Cardiol 1989;63:118-9. https://doi.org/10.1016/0002-9149(89)91093-X
  5. Berul CI, Van Hare GF, Kertesz NJ, Dubin AM, Cecchin F, Collins KK, et al. Results of a multicenter retrospective implantable cardioverter-defibrillator registry of pediatric and congenital heart disease patients. J Am Coll Cardiol 2008;51:1685-91. https://doi.org/10.1016/j.jacc.2008.01.033
  6. Bonney WJ, Spotnitz HM, Liberman L, Silver ES, Ceresnak SR, Hordof AJ, et al. Survival of transvenous ICD leads in young patients. Pacing Clin Electrophysiol 2010;33:186-91. https://doi.org/10.1111/j.1540-8159.2009.02600.x
  7. Botsch MP, Franzbach B, Opgen-Rhein B, Berger F, Will JC. ICD therapy in children and young adults: low incidence of inappropriate shock delivery. Pacing Clin Electrophysiol 2010;33:734-41. https://doi.org/10.1111/j.1540-8159.2010.02695.x
  8. Celiker A, Olgun H, Karagoz T, Ozer S, Ozkutlu S, Alehan D. Midterm experience with implantable cardioverter-defibrillators in children and young adults. Europace 2010;12:1732-8. https://doi.org/10.1093/europace/euq340
  9. Kwon HW, Lee SY, Kwon BS, Kim GB, Bae EJ, Kim WH, et al. Long QT syndrome and dilated cardiomyopathy with SCN5A p.R1193Q polymorphism: cardioverter-defibrillator implantation at 27 months. Pacing Clin Electrophysiol 2012;35:e243-6. https://doi.org/10.1111/j.1540-8159.2012.03409.x
  10. Choi KJ, Lee CW, Kim JJ, Kim YH. Implantable cardioverter-defibrillator (ICD) therapy in a patient with the long QT syndrome. Korean Circ J 1996;26:1198-203. https://doi.org/10.4070/kcj.1996.26.6.1198
  11. Hobbs JB, Peterson DR, Moss AJ, McNitt S, Zareba W, Goldenberg I, et al. Risk of aborted cardiac arrest or sudden cardiac death during adolescence in the long-QT syndrome. JAMA 2006;296: 1249-54. https://doi.org/10.1001/jama.296.10.1249
  12. Fananapazir L, Tracy CM, Leon MB, Winkler JB, Cannon RO 3rd, Bonow RO, et al. Electrophysiologic abnormalities in patients with hypertrophic cardiomyopathy: a consecutive analysis in 155 patients. Circulation 1989;80:1259-68. https://doi.org/10.1161/01.CIR.80.5.1259
  13. Silka MJ, Kron J, Dunnigan A, Dick M 2nd. Sudden cardiac death and the use of implantable cardioverter-defibrillators in pediatric patients. The Pediatric Electrophysiology Society. Circulation 1993;87:800-7. https://doi.org/10.1161/01.CIR.87.3.800
  14. Eicken A, Kolb C, Lange S, Brodherr-Heberlein S, Zrenner B, Schreiber C, et al. Implantable cardioverter defibrillator (ICD) in children. Int J Cardiol 2006;107:30-5. https://doi.org/10.1016/j.ijcard.2005.02.048
  15. Heersche JH, Blom NA, van de Heuvel F, Blank C, Reimer AG, Clur SA, et al. Implantable cardioverter defibrillator therapy for prevention of sudden cardiac death in children in the Netherlands. Pacing Clin Electrophysiol 2010;33:179-85. https://doi.org/10.1111/j.1540-8159.2009.02603.x
  16. Horner JM, Kinoshita M, Webster TL, Haglund CM, Friedman PA, Ackerman MJ. Implantable cardioverter defibrillator therapy for congenital long QT syndrome: a single-center experience. Heart Rhythm 2010;7:1616-22. https://doi.org/10.1016/j.hrthm.2010.08.023
  17. Hsia TY, Bradley SM, LaPage MJ, Whelan S, Saul JP, Ringewald JM, et al. Novel minimally invasive, intrapericardial implantable cardioverter defibrillator coil system: a useful approach to arrhythmia therapy in children. Ann Thorac Surg 2009;87:1234-8. https://doi.org/10.1016/j.athoracsur.2009.01.015
  18. Kriebel T, Ruschewski W, Paul T. Implantation of an "extracardiac" internal cardioverter defibrillator in a 6-month-old infant. Z Kardiol 2005;94:415-8. https://doi.org/10.1007/s00392-005-0236-z
  19. Lobodzinski SS. Subcutaneous implantable cardioverter-defibrillator (S-ICD). Cardiol J 2011;18:326-31.
  20. Panfilov I, Lever NA, Smaill BH, Larsen PD. Ventricular fibrillation frequency from implanted cardioverter defibrillator devices. Europace 2009;11:1052-6. https://doi.org/10.1093/europace/eup159
  21. Shah MJ. Implantable cardioverter defibrillator-related complications in the pediatric population. Pacing Clin Electrophysiol 2009; 32 Suppl 2:S71-4. https://doi.org/10.1111/j.1540-8159.2009.02389.x
  22. Von Bergen NH, Atkins DL, Dick M 2nd, Bradley DJ, Etheridge SP, Saarel EV, et al. Multicenter study of the effectiveness of implantable cardioverter defibrillators in children and young adults with heart disease. Pediatr Cardiol 2011;32:399-405. https://doi.org/10.1007/s00246-010-9866-7

Cited by

  1. Midterm Results of Implantable Cardioverter Defibrillators in Children and Young Adults from a Single Center in Turkey vol.39, pp.11, 2013, https://doi.org/10.1111/pace.12954
  2. Inappropriate ICD Shocks in Pediatric and Congenital Heart Disease Patients vol.8, pp.11, 2013, https://doi.org/10.19102/icrm.2017.081104
  3. Modern Technology for Prevention of Sudden Cardiac Death - a Clinical Update on Device Therapy in Children with Congenital Heart Diseases vol.4, pp.4, 2013, https://doi.org/10.2478/jce-2018-0027
  4. Implantable cardioverter‐defibrillator therapy to reduce sudden cardiac death in adults with congenital heart disease: A registry study vol.31, pp.8, 2013, https://doi.org/10.1111/jce.14633